![Insights from 2023 ASCO® Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2023/5/a2df459d-f523-49c6-86db-fbc880f4b695.png.200x0_q85.png)
Insights from 2023 ASCO® Annual Meeting
Head and Neck
Insights from 2023 ASCO® Annual Meeting
Enfortumab Vedotin in the Previously Treated Advanced Head & Neck Cancer Cohort of EV-202
FEATURING
Paul Swiecicki
- 217 views
- June 29, 2023
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL-IMMUNE & DEPEND"
FEATURING
Paolo Bossi
- 919 views
- June 16, 2023
- 6
Insights from 2023 ASCO® Annual Meeting
Immunotherapy Trials for Nasopharyngeal Cancers
FEATURING
Nabil Saba
- 382 views
- June 16, 2023
- 3